A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Df(2R)BSC136 heterozygotes do not exhibit significant defects in circadian rhythm under free-running (i.e. constant darkness) conditions, as compared to controls.
BrdU incorporation pattern and levels are not significantly different from wild type in homozygous cycle 15 and 16 embryos.
Flies heterozygous for the deletion do not show a Minute bristle phenotype.